Dear Eric,
Thanks for your response [*see note below]. As you say, it would be good to get different viewpoints, and not just from those in drug development. It would be great if HIFA members with other backgrounds shared their views.
As an aside, you or others with an interest in health R&D may be interested in WHO's Global Observatory on Health R&D which has a wealth of information for people to dive into. The interactive visualizations give information on funding flows, pipeline analysis etc.
https://www.who.int/observatories/global-observatory-on-health-research-...
Best wishes
Julie
Dr Julie N Reza
HIFA profile: Julie N Reza is a UK-based specialist in communications for biosciences, global health & international development (www.globalbiomedia.co.uk). She predominantly works with NGOs and not-for-profit organisations. Previously she was the senior science editor at TDR, based at the World Health Organization (WHO) in Geneva; prior to this she worked at the Wellcome Trust, UK, leading educational projects on international health topics including trypanosomiasis and trachoma. She has a PhD in immunology and a specialist degree in science communication. She also has several years research and postgraduate teaching experience. She is a member of the HIFA Steering Group and HIFA Social Media Working Group. www.hifa.org/people/steering-group
www.hifa.org/people/social-media
www.hifa.org/support/members/julie
Email: naimareza AT hotmail.com
[*Note from HIFA moderator (Neil PW): Eric van Praag wrote: "Reading the four key findings one still wonders what really hampers similar efforts for an HIV or other retroviral , viral, bacterial diseases in particular for those which are rampant in the poorer parts of the world. For some it is indeed more complex such as HIV but still the political and financial readiness we have never seen before applied to COVID-19 only. Or was it the potential very profitable market in the richer countries which played a role as well? I miss the sociologist or anthropological point of view." https://www.hifa.org/dgroups-rss/coronavirus-1450-covid-19-vaccines-fact... ]
